Up-regulation of cyclooxygenase-2 in different grades of acute human renal allograft rejection

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 4, 2007, Pages 235-243

  Rangel, Érika B ^a   Moura, Luiz A ^a   Franco, Marcello F ^a   Pacheco Silva, Álvaro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ACUTE GRAFT REJECTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INDUCTION; ENZYME REGULATION; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ADOLESCENT; ADULT; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 34247150230     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.01.005     Document Type: Article

References (21)

1. Rocha P.N., Plumb T.J., and Coffman T.M. Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin. Immunopathol. 25 2 (2003) 215-227
2. Hetu P.O., and Riendeau D. Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain. Biochem. J. 391 (2005) 561-566
3. Rangel E.B., Moura L.A., Franco M.F., and Pacheco-Silva A. Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection. Clin. Transplant 19 4 (2005) 543-550
4. Hoffmann U., Banas B., Kruger B., et al. Expression of cyclooxygenase-1 and cycloxygenase-2 in human renal allograft rejection-a prospective study. Transplant Int. 19 (2006) 203-212
5. Hausknecht B., Voelkl S., Riess R., Gauer S., and Goppelt-Struebe M. Expression of cyclooxygenase-2 in biopsies obtained from human transplanted kidneys undergoing rejection. Transplantation 76 1 (2003) 109-114
6. Ma N., Szabolcs M.J., Sun J., et al. The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection. Transplantation 74 11 (2002) 1528-1534
7. Paivaniemi O.E., Maasilta P.K., Alho H.S., and Wolff C.H. US Salminen, cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis. J. Pathol. 204 3 (2004) 340-348
8. Martelius T.J., Wolff H., Bruggeman C.A., Hockerstedt K.A., and Lautenschlager I.T. Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat. Transplant Int. 15 12 (2002) 610-614
9. Gysemans C., Stoffels K., Giulietti A., et al. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents. Diabetologia 46 8 (2003) 1115-1123
10. Feitoza C.Q., Câmara N.O., Pinheiro H.S. H.S., et al. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tisue damage triggered by ischemia and reperfusion injury. Int. Immunopharmacol. 5 1 (2005) 79-84
11. Kömhoff M., Gröne H.J., Klein T., Seyberth H.W., and Nüsing R.M. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am. J. Physiol. 270 (1997) F460-F468
12. Bustos M., Coffman T.M., Saadi S., and Platt J.L. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. J. Clin. Invest. 100 5 (1997) 1150-1158
13. Baker C.S., Hall R.J., Evans T.J., et al. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler. Thromb. Vasc. Biol. 19 3 (1999) 646-655
14. Burleigh M.E., Babaev V.R., Oates JA J.A., et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105 15 (2002) 1816-1823
15. Rabb H., Daniels F., O'Donnell M M., et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279 3 (2000) F525-F531
16. Dragun D., Bohler T., Nieminen-Kelha M., et al. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int. 65 3 (2004) 1076-1083
17. Yang X., Ma N., Szabolcs et al M.J. Upregulation of COX-2 during cardiac allograft rejection. Circulation 101 (2000) 430-438
18. Jose M.D., Ikezumi Y., van Rooijen N., Atkins R.C., and Chadban S.J. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76 7 (2003) 1015-1022
19. Messias N.C., Eustace J.A., Zachary A.A., Tucker P.C., Charney D., and Racusen L.C. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 72 4 (2001) 655-660
20. Harris R.C., Zhang M.Z., and Cheng H.F. Cyclooxygenase-2 and the renal rennin-angiotensin system. Acta Physiol. Scand. 181 (2004) S43-S47
21. Dragun D., Müller D.N., Bräsen J.H., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 352 6 (2005) 558-569